These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37395974)

  • 1. A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.
    Kim MC; Ahn Y; Kim MH; Kim SY; Hong TJ; Rhee MY; Kim SH; Hong SJ; Kim H; Kim W; Chae IH; Kang DH; Kim BK; Kim HS
    Am J Cardiovasc Drugs; 2023 Jul; 23(4):441-454. PubMed ID: 37395974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
    Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
    Kim TS; Rha SW; Kim SY; Park DG; Sung KC; Yoon MH; Kim KH; Lee HC; Kim WS; Kim YJ; Ahn JC; Rhee MY; Cha DH; Yoo BS; Park SH; Yoo KD; Jeon DW; Yoon YW; Cho SK; Oh YS
    Clin Ther; 2019 Apr; 41(4):728-741. PubMed ID: 30904178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
    Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS
    Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
    Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
    Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.
    Jo SH; Kang SM; Yoo BS; Lee YS; Youn HJ; Min K; Yu JM; Yoon HJ; Kim WS; Kim GH; Park JH; Kim SY; Kim CH
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.
    Kim W; Chang K; Cho EJ; Ahn JC; Yu CW; Cho KI; Kim YJ; Kang DH; Kim SY; Lee SH; Kim U; Kim SJ; Ahn YK; Lee CH; Shin JH; Kim M; Park CG
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):261-269. PubMed ID: 32003938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.
    Lee CJ; Kang WC; Ihm SH; Sohn IS; Woo JS; Kim JW; Hong SJ; Choi JH; Suh JW; Seo JB; Doh JH; Son JW; Park JH; Lee JH; Hong YJ; Heo JH; Shin J; Kang SM
    J Clin Hypertens (Greenwich); 2024 Mar; 26(3):262-273. PubMed ID: 38319595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study.
    Oh GC; Han JK; Han KH; Hyon MS; Doh JH; Kim MH; Jeong JO; Bae JH; Kim SH; Yoo BS; Baek SH; Rhee MY; Ihm SH; Sung JH; Choi YJ; Kim SJ; Hong KS; Lee BK; Cho J; Shin ES; Rhew JY; Kim H; Kim HS
    Clin Ther; 2018 May; 40(5):676-691.e1. PubMed ID: 29673890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong).
    Park JS; Shin JH; Hong TJ; Seo HS; Shim WJ; Baek SH; Jeong JO; Ahn Y; Kang WC; Kim YH; Kim SH; Hyon MS; Choi DH; Nam CW; Park TH; Lee SC; Kim HS
    Drug Des Devel Ther; 2016; 10():2599-609. PubMed ID: 27574399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
    Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
    Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.
    Kim BJ; Cha KS; Cho WH; Kim EJ; Choi SH; Kim MH; Kim SH; Park JB; Park SM; Sohn IS; Ryu KH; Chae IH
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231205204. PubMed ID: 37814541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.
    Hong SJ; Jeong HS; Ahn JC; Cha DH; Won KH; Kim W; Cho SK; Kim SY; Yoo BS; Sung KC; Rha SW; Shin JH; Han KR; Chung WS; Hyon MS; Lee HC; Bae JH; Rhee MY; Kwan J; Jeon DW; Yoo KD; Kim HS
    Clin Ther; 2018 Feb; 40(2):226-241.e4. PubMed ID: 29402522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.
    Jin X; Kim MH; Han KH; Hong SJ; Ahn JC; Sung JH; Cho JM; Lee HC; Choi SY; Lee K; Kim WS; Rhee MY; Kim JH; Hong SP; Yoo BS; Cho EJ; Lee JH; Kim PJ; Park CG; Hyon MS; Shin JH; Lee SH; Sung KC; Hwang J; Kwon K; Chae IH; Seo JS; Kim H; Lee H; Cho Y; Kim HS
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1835-1845. PubMed ID: 32937023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness and safety of amlodipine/losartan-based single-pill combination therapy in patients with hypertension: Findings from real-world, multicenter observational databases.
    Lee J; Choi J; Yum Y; Joo HJ; Kim YH; An H; Kim EJ
    J Clin Hypertens (Greenwich); 2021 Nov; 23(11):1975-1983. PubMed ID: 34714968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
    Volpe M; Junren Z; Maxwell T; Rodriguez A; Gamboa R; Gomez-Fernandez P; Ortega-Gonzalez G; Matadamas N; Rodriguez F; Dass B; Kyle C; Clarysse L; Bryce A; Moreno-Heredia E; Germano G; Gilles L; Smith RD; Sanderson JE;
    Clin Ther; 2003 May; 25(5):1469-89. PubMed ID: 12867222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy.
    Jeon ES; Lim SW; Kim SY; Yang HM; Kim MH; Rhee MY; Han SH; Shin J; Kim KI; Jeong JO; Sung KC; Hong GR; Kim HS; Kwon K; Kang TS; Lee HY; Han SE
    Clin Hypertens; 2022 Dec; 28(1):40. PubMed ID: 36451242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.